TRENTON, N.J. (AP) — U.S. regulators have approved a second gene therapy for blood cancer. The one-time treatment is for aggressive lymphoma in adults. The Food and Drug Administration approved sales of the therapy from Kite Pharma on Wednesday. The treatment involves removing immune system cells called T cells from a patient, reprogramming them to target and kill cancer cells and giving them back to the patient.
Comment on FDA OKs 2nd gene therapy for blood cancer; 1st for adults
By LINDA A. JOHNSON, AP Medical Writer, San Francisco Chronicle
Wed, 10/18/2017 - 4:03pm
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more